| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC | Director | Common Stock | 82,650 | $38,019 | $0.4600 | 12 Jun 2025 | Direct |
| SANGAMO THERAPEUTICS, INC | Director | Stock Option (Right to Buy) | 50,000 | 12 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGMO | SANGAMO THERAPEUTICS, INC | 12 Jun 2025 | 2 | $0 | 4 | Director | 16 Jun 2025, 16:05 |
| SGMO | SANGAMO THERAPEUTICS, INC | 04 Jun 2024 | 2 | $0 | 4 | Director | 06 Jun 2024, 16:23 |
| SGMO | SANGAMO THERAPEUTICS, INC | 01 Jun 2023 | 2 | $0 | 4 | Director | 05 Jun 2023, 16:46 |
| SGMO | SANGAMO THERAPEUTICS, INC | 15 Dec 2022 | 2 | $0 | 4 | Director | 19 Dec 2022, 16:02 |
| SGMO | SANGAMO THERAPEUTICS, INC | 15 Dec 2022 | 0 | $0 | 3 | Director | 19 Dec 2022, 15:27 |